Vireo Growth Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- John Mazarakis
- Full Time Employees
- 612
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 207 South 9th Street Minneapolis MN United States of America 55402
- IPO Date
- Mar 18, 2019
- CIK
- 0001771706
- Website
- vireogrowth.com
- Similar Companies
- Business
- Vireo Growth Inc. engages in the cultivation, production, and distribution of cannabis products through state-licensed subsidiaries in the United States, operating retail and wholesale channels under its Green Goods and related brands. The company focuses on growing, processing, and selling medical and adult-use cannabis across multiple markets, including Minnesota, Maryland, and New York, with expansion plans guided by licensed cultivation, manufacturing, and dispensary operations. Headquarters are in Minneapolis, Minnesota, and the company is publicly listed on the Canadian Securities Exchange (ticker: VREO) with additional trading on OTC markets. Founded in 2014, Vireo Growth leverages a diversified portfolio of cannabis brands, strategic M&A activity, and debt refinancing to scale its footprint and product offerings across its three core markets. Primary products and services include cultivation and processing of cannabis extracts and products; wholesale distribution to licensed dispensaries; and direct retail through owned Green Goods dispensaries and partner networks. The company’s strategy centers on building a multi-market platform with scalable cultivation capacity, branded product lines, and integrated supply to accelerate revenue growth and profitability. Subsidiaries hold operating licenses enabling controlled production, packaging, and distribution, while strategic partnerships and acquisitions broaden brand reach and product innovation across the cannabis ecosystem. Vireo Growth emphasizes compliance, quality assurance, and patient-focused or adult-use products designed to serve both medical and recreational customers.
Company News
Vireo Growth Inc. Announces Financing for New York and Florida Cultivation Facility
Vireo Growth Inc. Announces Put/Call Agreement in Connection with Loan Acquisition
Vireo Growth Inc. Completes Acquisition of M3 Wellness, a Nevada Dispensary
Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore Settlement
Vireo Growth Announces Conference Attendance for September 2026
Vireo Growth Inc. Completes Acquisition of C21 Investments Inc.
Vireo Growth Inc. (VREOF) Q2 2026 Earnings Call Transcript
Vireo Growth Announces Asset Based Credit Facility
Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assets
Vireo Growth to Report Second Quarter 2026 Financial Results on August 11, 2026
Vireo Growth to Report Second Quarter 2026 Financial Results on August 11, 2026
Vireo Growth Inc. Announces a Four-Deal Transaction to Establish Presence in Ohio
Vireo Growth Inc. to Acquire Certain Assets of The Cannabist Company Holdings Inc.
Vireo Growth Inc. Completes Acquisition of Pennsylvania Dispensary License Transaction
Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker
Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker
Vireo Growth Inc. Announces Pennsylvania Dispensary License Transaction, Expanding into its 11th State
Vireo Growth Inc. Completes Acquisition of Equity Interest in Maryland Dispensaries
Vireo Growth Inc. Appoints BDO as its New Auditor
Vireo Growth Inc. Completes Acquisition of Bridgewell Agribusiness LLC and Plans to Acquire Dispensaries in Nevada and Maryland